Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava

BACKGROUND: Tobacco use is the leading cause of many preventable diseases, resulting in premature death or disease. Given that the majority of adult who smoke want to stop, this health burden could be significantly reduced if the success rate of tobacco cessation can be improved. In addition, most a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Chengguo, Malaty, John, Malham, Melissa Bou, Nehme, Anna Maria Abi, Freeman, Breanne, Huo, Zhiguang, Firpi-Morrel, Roberto, Salloum, Ramzi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847434/
https://www.ncbi.nlm.nih.gov/pubmed/36653872
http://dx.doi.org/10.1186/s13063-023-07081-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847434/
https://www.ncbi.nlm.nih.gov/pubmed/36653872
http://dx.doi.org/10.1186/s13063-023-07081-x

Ejemplares similares